StartAngels Network

Calingo is a digital insurance platform that specializes in providing personalized and optimized risk protection directly at the point of sale. The company focuses on offering customized insurance products designed to meet individual customer needs, ensuring transparency and fairness in pricing. By leveraging technology, Calingo aims to deliver tailored insurance solutions that are both suitable and transparent for customers.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Oxfia is an energy optimization platform. It can optimize and monitor existing building technology without human interaction and lower energy costs in the building process. They specialize in reducing carbon dioxide emissions and energy costs associated with the operation of building systems, enabling people to minimize their building's energy costs and reduce controllable energy consumption.

Pipra is a MedTech startup focused on developing innovative tools aimed at preventing, predicting, and diagnosing delirium, particularly postoperative delirium, which significantly affects older patients and incurs substantial costs for healthcare systems. The company offers an AI-driven clinical decision support software designed to help healthcare professionals identify patients at high risk of developing postoperative delirium prior to surgery. The tool utilizes standard medical data and delivers a risk assessment in under two minutes through a web or app-based platform. This capability allows medical staff to tailor operative plans and implement clinical interventions, ultimately reducing the incidence of postoperative delirium by up to 53%. Currently, Pipra's technology is operational in three hospitals, with plans to expand to 22 additional facilities across Europe. The company's advisory board includes notable experts from prestigious institutions such as Johns Hopkins, Harvard, and Cornell, further underscoring its commitment to addressing this critical healthcare issue.

Rebels 0.0% is a company dedicated to creating truly alcohol-free spirits, aiming to provide consumers with enjoyable alternatives for social drinking. By developing beverages that can be mixed with various drinks while containing no alcohol, Rebels 0.0% promotes a social mission to empower individuals in their choices regarding alcohol consumption. The brand emphasizes the importance of freedom of choice, allowing people to partake in social experiences without the effects of alcohol.

Inergio is a spin-off from the École Polytechnique Fédérale de Lausanne that specializes in the development of advanced fuel cell technology. The company focuses on creating portable energy units that deliver ten times the power while being half the weight of existing solutions. Founded by Mahmoud Hadad, Inergio's innovative fuel cell design utilizes readily available and safe fuels like butane and propane, providing high autonomy for various applications. This modular and miniaturized power system is aimed at addressing the challenge of reliable energy supply, offering a clean, efficient, and lightweight solution. The technology is versatile, suitable for diverse applications, including charging consumer electronics, supplying auxiliary power for drones, and serving as automobile fuel cells. Inergio has developed a working prototype and is in the process of preparing a minimal viable product to initiate pilot projects with potential partners and customers.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

CompPair Technologies Ltd. is a manufacturer specializing in smart and bio-inspired healable structural composites designed to extend the lifespan of composite materials. Founded in 2019 and based in Lausanne, Switzerland, the company evolved from extensive research conducted at the Laboratory for Processing of Advanced Composites at EPFL, drawing on over a decade of expertise in self-healing composites. CompPair's innovative offerings include smart prepreg, which significantly reduces maintenance costs, facilitates damage healing, and enhances the sustainability of composite products. The company serves a diverse range of industries, including aerospace, automotive, wind energy, and sports, providing solutions that not only improve product longevity but also promote easier recycling at the end of a product's life cycle.

CompPair Technologies Ltd. is a manufacturer specializing in smart and bio-inspired healable structural composites designed to extend the lifespan of composite materials. Founded in 2019 and based in Lausanne, Switzerland, the company evolved from extensive research conducted at the Laboratory for Processing of Advanced Composites at EPFL, drawing on over a decade of expertise in self-healing composites. CompPair's innovative offerings include smart prepreg, which significantly reduces maintenance costs, facilitates damage healing, and enhances the sustainability of composite products. The company serves a diverse range of industries, including aerospace, automotive, wind energy, and sports, providing solutions that not only improve product longevity but also promote easier recycling at the end of a product's life cycle.

Typewise AG is a Swiss deep tech company established in 2019 and headquartered in Binningen, Switzerland. It specializes in developing innovative text prediction technology and offers a range of products aimed at enhancing communication efficiency. The flagship product, the Typewise Keyboard, is an award-winning app available for iOS and Android that supports over 30 languages and includes features like a custom dictionary and predictive text capabilities, specifically catering to users in multilingual contexts, including support for Hinglish. Additionally, Typewise provides an AI Writing Assistant, a browser-based tool designed to improve the speed and quality of written communication, particularly for customer service and sales teams. The company also offers a Text Prediction API that allows developers to integrate its advanced text prediction capabilities into their own applications, thereby enhancing user experience and productivity. With nearly 2 million installations of its keyboard app, Typewise aims to make everyday communication easier and more efficient.

Hystrix Medical operates a digital marketplace designed to streamline the procurement process for medical devices and repeat purchase products within hospitals. The platform connects healthcare organizations with suppliers, significantly reducing the typical 4-6 month contracting timeline by providing a comprehensive one-stop shop that establishes a transparent market price landscape. It focuses on medical products that require minimal explanation for transaction, aiming to enhance the efficiency of hospital personnel and suppliers. By facilitating easier and more effective procurement and sales, Hystrix Medical has demonstrated an average total cost savings of 40% for its users, making it a valuable resource in the healthcare supply chain.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Diviac is a prominent online travel agency specializing in scuba diving, founded in December 2012 in Switzerland. The platform aims to inspire divers to explore more destinations and contribute to ocean conservation. Diviac offers an extensive selection of dive holidays, surpassing competitors in both variety and accessibility. It caters to both group and individual travelers, combining a user-friendly online booking experience with personalized guidance from a global team of scuba travel experts. Additionally, Diviac is committed to sustainability, having launched Diviac Eco Travel, which provides divers with opportunities to engage in vacations that positively impact ocean conservation efforts.

Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Divicom is a group of companies specializing in health, with 16 years of history. The experience of their professionals allows Divicom the provision of high quality services with attention constant improvement of cost - effectiveness.

Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery industry. Founded in 2009 and headquartered in Wädenswil, Switzerland, with an additional office near Boston, Creoptix focuses on next-generation bioanalytical instruments that leverage proprietary sensor and microfluidics technology. Their flagship product, the Creoptix WAVEsystem, utilizes Grating-Coupled Interferometry (GCI) technology to offer high sensitivity and resolution for real-time analysis of biological interactions, accommodating various samples, including small molecules, peptides, and biologics in complex biofluids like serum and plasma. The company also provides instrument sets for fragment-based screening and binding analysis, versatile sensors for carboxyl-coupling of various molecules, and integrated software for assay setup and data evaluation, catering to both industry and academic research needs.

Leman Micro Devices SA, founded in 2013 and based in Lausanne, Switzerland, specializes in innovative health monitoring technologies for mobile devices. The company is renowned for developing the V-Sensor, a groundbreaking miniature device that accurately measures five vital signs: blood pressure, blood oxygen, respiration rate, pulse rate, and body temperature. This device operates without the need for cuffs or calibration and provides results on-screen within one minute through the LMD e-Checkup app. With a focus on regulated consumer healthcare products, Leman Micro Devices aims to enhance personal health monitoring by integrating its technology into smartphones and wearables, thus enabling users to conveniently track their health metrics. The V-Sensor was launched at CES 2021, marking the company's entry into the health technology market.

Credentis AG, established in 2010 and headquartered in Windisch, Switzerland, specializes in the research, development, production, and distribution of innovative oral hygiene products. The company focuses on preventing and treating dental diseases, offering solutions such as CURODONT for hypersensitivity treatment and CUROLOX for post-bleaching care. Their product portfolio also includes Curodont Repair, Protect, and D’Senz, targeting caries lesions and related issues. Credentis aims to provide dentists with effective tools and patients with products that regenerate, protect, and desensitize teeth.

Attolight is a developer of advanced instrumentation focused on time-resolved cathodoluminescence, which is essential for measuring carrier dynamics in nanostructures. The company's innovative products integrate cathodoluminescence with light and electron microscopy, transforming complex experiments into streamlined processes. Attolight's technology enables researchers to conduct studies with nanometer resolution and pico-second timing, facilitating the analysis of various materials, particularly semiconductors, phosphors, ceramics, rocks, and glass. By combining multiple imaging techniques, Attolight's solutions can identify ultra-trace impurities and crystallographic defects that remain undetectable with conventional imaging methods. This unique capability enhances the efficiency of material studies and contributes to advancements in fields such as LED, laser diode, and solar cell development.

Viroblock is a Swiss company dedicated to the development of advanced antiviral technology that acts rapidly and has a broad spectrum of efficacy. Their innovative technology is integrated into non-woven fabrics, making it particularly effective for air filtration products. Viroblock's fabric has demonstrated the ability to eliminate over 99% of H5N1 viruses in standardized aerobiology tests. The company employs a unique mechanism of action that enables the inactivation of enveloped viruses, including various strains of influenza, the SARS virus, and the AIDS virus. This broad-spectrum approach allows Viroblock to address multiple virus families without leading to the development of viral resistance, enhancing treatment options for patients affected by viral diseases.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Attolight is a developer of advanced instrumentation focused on time-resolved cathodoluminescence, which is essential for measuring carrier dynamics in nanostructures. The company's innovative products integrate cathodoluminescence with light and electron microscopy, transforming complex experiments into streamlined processes. Attolight's technology enables researchers to conduct studies with nanometer resolution and pico-second timing, facilitating the analysis of various materials, particularly semiconductors, phosphors, ceramics, rocks, and glass. By combining multiple imaging techniques, Attolight's solutions can identify ultra-trace impurities and crystallographic defects that remain undetectable with conventional imaging methods. This unique capability enhances the efficiency of material studies and contributes to advancements in fields such as LED, laser diode, and solar cell development.

VirtaMed AG, founded in 2007 and headquartered in Schlieren, Switzerland, specializes in the development and production of high-fidelity surgical simulators designed for medical training. The company offers a range of simulators focused on orthopedics, obstetrics and gynecology, laparoscopy, and urology, as well as custom-made solutions. VirtaMed's innovative simulators utilize advanced data analytics and virtual medical reality technology to provide trainees with realistic surgical experiences, enabling them to progress through increasingly complex scenarios. By collaborating with hospitals, medical societies, and life science companies, VirtaMed integrates its simulation products into medical education, enhancing training programs and reducing costs related to disposable materials. With a commitment to promoting surgical excellence, VirtaMed aims to empower surgeons to achieve proficiency through intelligent simulation.